News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dana-Farber is teaming up with Fitbit to test if weight loss can help prevent breast cancer recurrence among overweight women with early stage disease. This first of its kind study has potential to create a new standard of treatment for millions of breast cancer patients around the world.

Tags: BreastCancer, Exercise

  • William G. Kaelin, Jr., MD, of Dana-Farber has received the 10th annual Princess Takamatsu Award for "novel and significant work" in cancer from the American Association for Cancer Research (AACR).

Tags: Honors

  • One-third of patients with metastatic melanoma in a phase 1 clinical trial have survived five years after treatment with the immunotherapy drug nivolumab, which blocks the PD-1 immune checkpoint, reports a Dana-Farber Cancer Institute scientist.

Tags: Melanoma, Immunotherapy

  • Colorectal cancers heavily bedecked with tumor-related proteins called neoantigens are likely to be permeated with disease-fighting white blood cells, researchers at Dana-Farber report in a new study.

Tags: ColonCancer

  • Testing experimental cancer drugs in mouse models with patient-derived tumors could reduce the high failure rate of drugs in early clinical trials, according to a report from Dana-Farber Cancer Institute scientists.

Tags: BasicResearch

  • A simple blood test can rapidly and accurately detect mutations in two key genes in non-small cell lung tumors, researchers at Dana-Farber Cancer Institute report in a new study.

Tags: LungCancer

  • Dana-Farber will be joining the Collaborative Cancer Cloud, a precision medicine analytics platform that will increase speed and affordability to data-sharing.

Tags: Partnerships

  • Scott A. Armstrong, MD, PhD, an internationally renowned pediatric hematologist/oncologist, has been named Chair of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute, and the David G. Nathan Professor of Pediatrics at Dana-Farber Cancer Institute, Boston Children’s Hospital, and Harvard Medical School. He will also serve as Associate Chief of the Division of Hematology and Oncology at Boston Children’s Hospital.

Tags: Appointments, ChildhoodCancer

  • Dana-Farber Cancer Institute researchers are leading a multicenter genetic study of prostate cancer in Sub-Saharan Africa to try to find new information about the genetic etiology of prostate cancer.

Tags: ProstateCancer

  • Dana-Farber researchers identify new agent that resensitizes drug-resistant HER2-positive breast cancer tumors to front-line therapies in preclinical study. This discovery will lead to the launch clinical trial of the new agent in women with a metastatic form of the disease.

Tags: BreastCancer, TargetedTherapy

Showing 1-10 of 680 items